Wave Life Sciences Ltd. (WVE)
NGM – Real Time Price. Currency in USD
5.36
+0.32 (6.34%)
Market open: Aug 12, 2026, 10:41 AM EDT
5.25
+0.20 (4.06%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
5.36
+0.32 (6.34%)
Market open: Aug 12, 2026, 10:41 AM EDT
5.25
+0.20 (4.06%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $368.0M significantly exceed its total debt $43.6M, ensuring strong financial flexibility
Total current assets $507.5M exceed Total current liabilities $50.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$54.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.99 | 6.05 | 10 | |
| Quick ratio | 9.99 | 5.63 | 10 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.08 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 113M | 108M | 43M | 65M |
| Gross Profit | -6M | 104M | 100M | 34M | 56M |
| Operating Income | -163M | -68M | -110M | -215M | -218M |
| Net Income | -162M | -58M | -97M | -204M | -202M |
| EBITDA | -153M | -59M | -102M | -207M | -209M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -25.71 | 0.72 | 1.5 |
| Next quarter | -61.23 | -8.56 | 1.0 |
| Current year | 23.63 | 8.59 | 8.0 |
| Next year | -10.98 | -18.18 | 1.0 |
| Weighted average score | 2.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -94.05 | -165.85 | -161.53 | 9.54 | 2.3 |
| Y/Y | -73.87 | -37.41 | -9.67 | -12.45 | 1.0 |
| 3y average | 980.05 | -38.28 | -9.59 | -193.11 | 3.3 |
| 5y average | 590.62 | -25.75 | 4.51 | -119.97 | 4.0 |
| Weighted average score | 2.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |